Short-term Spinal Stimulation Effects in Cerebral Palsy

ClinicalTrials.gov ID: NCT07826494

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07826494. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 13, 2026, 3:46 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Acute Effects of Transcutaneous Spinal Stimulation on Spasticity and Gait in Cerebral Palsy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This research study will examine the acute effects of non-invasive spinal stimulation on spasticity and walking in individuals with cerebral palsy. The hypothesis is that walking with spinal stimulation will lead to greater reductions in spasticity than walking without spinal stimulation. Additionally, it is hypothesized that the average step length and Gait Deviation Index will be higher while walking with spinal stimulation compared to walking without spinal stimulation.

Study identification

NCT ID: NCT07826494
Recruitment status: Recruiting
Study type: Interventional
Phase: Not applicable
Lead sponsor: University of Washington; Other
Enrollment: 20 participants

Conditions and interventions

Conditions

Cerebral Palsy

Interventions

Spinal Stimulation Device
Treadmill Walking Other

Device · Other

Eligibility (public fields only)

Age range: 4 Years to 65 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 13, 2026 (Actual)
Primary completion: Jun 1, 2028 (Estimated)
Completion: Dec 1, 2028 (Estimated)
Last update posted: Sep 17, 2026

2026 – 2028

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
University of Washington	Seattle	Washington	98195	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07826494, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Sep 17, 2026 · Synced Nov 13, 2026